Halozyme Therapeutics, Inc. HALO

Set alert

101.68 USD -1.30 (-1.26%)

At closeNov 11, 2026, 4:03 PM EST

101.99 +0.31 +0.30%

After hours · Nov 11, 4:03 PM ET

99.27 Day range 102.62

61.23 52-week range 134.00

Held by insiders 1.08%

Held by institutions 112.85%

Float held by institutions 114.08%

Institutions 990

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	11.64%	13,271,095	1.35B	Jun 29, 2026
Vanguard Capital Management LLC	4.69%	5,351,312	544.12M	Jun 29, 2026
Vanguard Portfolio Management LLC	4.65%	5,299,008	538.80M	Jun 29, 2026
State Street Corporation	4.54%	5,179,434	526.64M	Jun 29, 2026
Invesco Ltd.	2.79%	3,177,997	323.14M	Jun 29, 2026
Morgan Stanley	2.48%	2,832,594	288.02M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
iShares Trust-iShares Core S&P Mid-Cap ETF	3.55%	4,042,836	411.08M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	3.30%	3,762,787	382.60M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	2.39%	2,721,119	276.68M	Jun 29, 2026
John Hancock Funds III-Disciplined Value Mid Cap Fund	1.47%	1,679,285	170.75M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund	1.37%	1,566,912	159.32M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	1.21%	1,375,999	139.91M	Sep 29, 2026

HALO insiders
Insider	Relation	Latest transaction	Date	Shares held
CONNAUGHTON BERNADETTE M.	Director	Sale	Aug 9, 2026	40,418
DUNCAN BARBARA GAYLE	Director	Stock Award(Grant)	May 4, 2026	23,715
HENDERSON JEFFREY WILLIAM	Director	Stock Award(Grant)	May 4, 2026	36,572
LABARRE MICHAEL J.	Chief Technology Officer	Sale	Feb 26, 2025	173,756
LABROSSE NICOLE	Chief Financial Officer	Conversion of Exercise of derivative security	Feb 22, 2026	38,494
MATSUI CONNIE L	Director	Stock Gift	Nov 28, 2024	183,035

Held by funds